Seattle, WA -- (SBWIRE) -- 09/23/2019 -- The urinalysis test measures elements found in urine, such as hormones, electrolytes, and waste products formed during metabolism. It is also known as urine test and includes various tests to measure various components passing through urine. This test assists pathologists and clinicians to identify problems that require treatment such kidney problem and infection. The urine test is bifurcated into three parts namely visual examination, microscopic examination, and dipstick test. This is a routine medical checkup, pre-surgery precreation, pregnancy check-up, or hospital admission checkup for various disorders. These disorders include kidney disorders, liver problems, urinary tract infections, diabetes, or other metabolic conditions. In some cases, clinicians recommend for additional screening and tests to further examine findings of urine tests or specific features of core problems. For instance, urinary tract infections is identified by urinalysis, while the urine culture is identified by follow-up test to spot the bacteria that may be responsible for the infection.
Get PDF Brochure of Research Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/382
According to Centers for Disease Control and Prevention, as of 2016, around 4.9 million people in the U.S. are diagnosed with kidney disease. The major factors that are driving the growth of market are escalating prevalence of kidney diseases and urinary tract infections, technological advancements, increasing adoption rate of point-of-care urinalysis devices, implementation of Patient Protection and Affordable Care Act (PPACA), increasing healthcare expenditure and increasing senior citizen population.
Urinalysis Market Taxonomy
On the basis of product type, the urinalysis market is classified into the following:
- Consumables
- Instruments
On the basis of test type, the urinalysis market is classified into following:
- Biochemical Urinalysis
- Sediment Urinalysis
On the basis of end user, the urinalysis market is classified into following:
- Hospitals
- Diagnostics Laboratories
- Research Laboratories and Institutes
- Home-care Settings
Urinalysis Market Dynamics
According to Centers for Disease Control and Prevention (CDC), in 2016, diabetes was one of the most chronic disease in the U.S, accounting for 29.1million people or 9.3% of the U.S population. Growing prevalence of chronic diseases such as diabetes coupled with increasing geriatric population is expected to support growth of global urinalysis market during the forecast period. Furthermore, growing use portable and battery operated urinalysis devices and increasing implementation of urinalysis in emerging economies such as India and China is expected to drive the market growth. Introduction of urinalysis via smartphones and integrated systems coupled with technological advancement are expected to create lucrative growth opportunities in the global urinalysis market.
High costs of R&D, implementation of excise tax by the U.S. government and stringent regulatory procedures are major factors that hinder the growth of the market. The large target population and the observed high, unmet clinical needs in the developing regions provide the market with a large pool of opportunities for prospective growth. To exploit on these opportunities, the development of diagnostic tools that can respond to these unmet clinical needs at reasonable price is mandatory.
Regional Analysis
North America is the largest region in the urinalysis market. The major driver for the large market share includes presence of key market players in the region such as Alere, Inc., Bio Rad, Siemens Healthcare, and Beckman Coulter. Moreover, introduction of the automated urine sediment analyzers such as digital flow morphology (digital imaging) & fluorescence flow cytometry together with high healthcare expenditure in this region. Asia Pacific is expected to observe the fastest growth during the forecast period. Increasing penetration rate of advanced urine analyzers, and the presence of local urine analyzer manufacturers, such as Mindray, Urit medical, and a large base of the target population with unmet clinical needs are expected to strengthen the market growth over the forecast period.
Key players operating in the urinalysis market are
Alere
Bio Rad
Roche Diagnostics
Mindray
Arkray, Inc.
Sysmex
Siemens Healthcare
To Know More About Urinalysis Market Report: https://www.coherentmarketinsights.com/ongoing-insight/urinalysis-market-382
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.